G

GenesisCare UK

Global cancer and cardiac care network

Patient Administration Officer

Part-TimeUpdated on 10/23/2026
No salary listed
Mid
Chelmsford, UK
In Person
Medical, Clinical & VeterinaryClinical Support & Patient Administration

About the job

Requirements
  • Previous administration and customer service experience in a busy environment.
  • Excellent communication and interpersonal skills.
  • A caring, empathetic and professional approach to patient care.
  • Strong organisational skills with excellent attention to detail.
  • Confidence managing multiple priorities and working collaboratively within a multidisciplinary team.
  • Good knowledge of Microsoft Office, including Outlook, Word and Excel.
Responsibilities
  • Coordinate patient referrals and appointments accurately and efficiently.
  • Be the first point of contact for patients, providing customer service both in person and over the phone.
  • Contact patients promptly following referral to guide them through their treatment journey.
  • Liaise with consultants, clinical teams, NHS Trusts and internal departments to ensure smooth patient pathways.
  • Schedule appointments and maintain accurate patient records within MOSAIQ.
  • Support reception activities, welcoming patients and visitors to the centre.
  • Maintain confidentiality and ensure compliance with GenesisCare policies and procedures.
  • Help deliver an outstanding patient experience by arranging additional support services where appropriate.
  • Support continuous improvement by maintaining quality standards and assisting with training new team members.
Desired Qualifications
  • Previous healthcare administration experience.
  • Experience using MOSAIQ.

About the company

GenesisCare UK operates a network of multi-specialty clinics focusing on cancer and cardiac care. It offers services such as advanced radiation therapy, medical oncology, and diagnostics, supported by sleep and cardiac services added through growth. The model combines hospital-grade treatments with outpatient care across centers, delivering treatments via insurance reimbursements, government funding, and private-pay options. Treatments are delivered through centralized access to devices and clinicians, enabling integrated care from diagnosis through treatment. Unlike some competitors, GenesisCare emphasizes a patient-centric approach and international expansion, including the UK, Australia, the U.S., and other markets, using acquisitions and new centers to broaden access. Its goal is to improve patient outcomes by providing comprehensive, connected cancer and heart care across a network of clinics.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$225.2M

Headquarters

Sydney, Australia

Founded

2004

Get referred to GenesisCare UK

See people who can refer or advise you

Benefits

  • Paid Vacation
  • Health Insurance
  • Dental Insurance
  • Disability Insurance
  • Wellness Program
  • Mental Health Support
  • Employee Discounts

Growth & Insights and Company News

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Yahoo Finance
Sep 8th, 2026
GenesisCare brings ZAP-X brain radiosurgery platform to Australia at St Vincent's Hospital Sydney

ZAP Surgical Systems announced that GenesisCare will become the first cancer care provider in Australia to offer the ZAP-X Gyroscopic Radiosurgery platform. The installation at GenesisCare's centre at St Vincent's Hospital Sydney is expected to begin this month, with first patient treatments anticipated before year-end. The ZAP-X system provides patients with brain tumours a non-invasive alternative to open surgery, delivering treatment in a single outpatient session without anaesthesia or incisions. The platform uses gyroscopic mobility to deliver radiosurgical beams from thousands of angles, designed to minimise radiation exposure to healthy brain tissue. The addition will expand GenesisCare's neuro-oncology capabilities in Sydney, enabling delivery of dedicated stereotactic radiosurgery. Previously, such patients were primarily treated using cobalt-60-based systems and multi-purpose radiotherapy linear accelerators.

Construction Enquirer
Jun 17th, 2026
G&H lands £16m brace of M&E deals.

G&H lands £16m brace of M&E deals. Grant Prior 21 minutes ago G&H G&H has won more work in the healthcare sector with two mechanical, electrical and public health (MEP) contract wins worth a combined £16.3m with new client Elliott Group and existing client HBC Construction. Elliott Group has appointed MEP to deliver Affidea's flagship medical centre at Wimbledon Quarter - the first private medical centre to be located in a UK retail destination. Opening late 2026, the centre will provide private GP care, a minor injuries unit, advanced diagnostic imaging and specialist outpatient treatments. G&H's 60-strong team, including apprentices, will deliver a full MEP design and build package, with pipework prefabricated at its Leeds-based workshop. Shaun Atkinson, fit out director at Elliott Group said: "It's a fantastic project that will bring high-quality healthcare services closer to the local community and create a modern facility that people can access easily when they need it. "Affidea has a clear vision for what this centre can offer, and we're proud to be helping deliver it. We look forward to building a strong working relationship with G&H and the wider project team as the development progresses." HBC Construction, formerly Henry Boot Construction, has appointed G&H to deliver a complete MEP design and build for GenesisCare, the UK's largest cancer care provider, at their pioneering new facility in Leeds. A 55-strong team will install specialist MRI and PET-CT process chillers and associated pipework, medical gas systems, and critical electrical infrastructure including Isolated Power Supply (IPS) and Uninterruptible Power Supply (UPS) systems to maintain continuity in the event of a power cut. David Wilson, operations manager north at G&H said: "These are significant healthcare schemes and my team are looking forward to working with HBC Construction again." Paul Cuss, operations director south at G&H said: "We're also pleased to be working with Elliott Group for the first time. Both this and the GenesisCare projects highlight the growing demand for high-quality, low-carbon building services in clinical environments." Lee Powell, managing director at HBC Construction said: "Our relationship with GenesisCare has allowed us to understand their key priorities and develop an accelerated programme for timely installation of specialist equipment. We look forward to working with G&H in our delivery of this pioneering research centre." G&H has successfully delivered numerous healthcare MEP projects over the past decade and is currently delivering two decarbonisation schemes at Heartlands Hospital in Birmingham and Hereford County Hospital, as well as collaborating with Morgan Sindall Construction on Harrogate District Hospital.

Bournemouth Echo
Jun 15th, 2026
New private cancer care facility to launch at Poole Hospital.

New private cancer care facility to launch at Poole Hospital. Poole Hospital (Image: PHILIP HARTLEY) A NEW partnership is set to provide Dorset residents with private cancer services, bringing more than £50 million of investment into NHS cancer care over the next 20 years. University Hospitals Dorset (UHD) is teaming up with GenesisCare UK to launch a private patient cancer facility at Poole Hospital, offering radiotherapy and Systemic Anti-Cancer Therapy (SACT) services, including chemotherapy and immunotherapy. The investment will increase capacity, help patients begin treatment sooner, and fund the recruitment of additional consultants to support NHS care. Dr Ben Masters, lead oncologist at UHD, said: "The deal is really beneficial to its NHS as the income generated can be reinvested in NHS care. "M35design can also use GenesisCare's expertise to benefit patients here in Dorset. "GenesisCare's bid stood out because of their focus on exemplary patient care, the latest innovations in evidence-based treatments, research and committing to long-term resources that enables the recruitment of more NHS staff." The facility will serve patients with medical insurance or those wishing to self-pay. Paul Gearing, chief growth officer at GenesisCare, said: "This is an exciting milestone for GenesisCare and a significant investment into the future of cancer care in Dorset. "We have long believed there is a strong demand for greater access to private cancer services in the region, and this partnership creates a unique opportunity to meet that need with a purpose-built, dedicated private patient unit, located alongside the NHS." Designs are being finalised, with plans to offer this dedicated services from autumn 2027.

PR Newswire
May 14th, 2026
GenesisCare rolls out SeeTreat's ART.1 software across 40+ Australian centres for adaptive radiotherapy monitoring

GenesisCare, Australia's leading cancer care provider, is collaborating with SeeTreat to deploy ART.1 software across more than 40 radiation oncology centres from July 2026. The technology enables automated, adaptive treatment evaluation for eligible cancer patients. The partnership follows a multidisciplinary study of 64 head and neck, breast and prostate cancer patients, which demonstrated significant benefits in standardising and scaling adaptive workflows. The software helps identify which patients would benefit from adjusted treatment plans during therapy, addressing anatomical changes that can cause unwanted side effects. SeeTreat, founded in 2023, has UKCA mark, CE mark and Australian ARTG registration, with FDA approval pending. GenesisCare treats over 35,000 patients annually across more than 50 Australian locations.